Literature DB >> 29042004

Quantitative, functional MRI and neurophysiological markers in a case of Gerstmann-Sträussler-Scheinker syndrome.

Silvia Marino, Rosa Morabito, S De Salvo, L Bonanno, A Bramanti, P Pollicino, R Giorgianni, Placido Bramanti.   

Abstract

Gerstmann-Sträussler-Scheinker syndrome (GSS) is an inherited autosomal dominant prion disease, caused by a codon 102 proline to leucine substitution (P102L) in the prion protein gene (PRNP). We describe the case of a 40-year-old male, affected by a slowly progressive gait disturbance, leg weakness and cognitive impairment. Genomic DNA revealed a point mutation of PRNP at codon 102, resulting in P102L, and the diagnosis of GSS was confirmed. Somatosensory evoked potentials showed alterations of principal parameters, particularly in the right upper and lower limbs. Laser-evoked potentials were indicative of nociceptive system impairment, especially in the right upper and lower limbs. Conventional magnetic resonance imaging (MRI) revealed marked atrophy of the vermis and cerebellar hemispheres and mild atrophy of the middle cerebellar peduncles and brainstem, as confirmed by a brain volume automatic analysis. Resting-state functional MRI showed increased functional connectivity in the bilateral visual cortex, and decreased functional connectivity in the bilateral frontal pole and supramarginal and precentral gyrus. Albeit limited to a single case, this is the first study to assess structural and functional connectivity in GSS using a multimodal approach.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29042004      PMCID: PMC5726351          DOI: 10.11138/fneur/2017.32.3.153

Source DB:  PubMed          Journal:  Funct Neurol        ISSN: 0393-5264


  21 in total

1.  Improved optimization for the robust and accurate linear registration and motion correction of brain images.

Authors:  Mark Jenkinson; Peter Bannister; Michael Brady; Stephen Smith
Journal:  Neuroimage       Date:  2002-10       Impact factor: 6.556

2.  Prion Protein Prolines 102 and 105 and the Surrounding Lysine Cluster Impede Amyloid Formation.

Authors:  Allison Kraus; Kelsie J Anson; Lynne D Raymond; Craig Martens; Bradley R Groveman; David W Dorward; Byron Caughey
Journal:  J Biol Chem       Date:  2015-07-14       Impact factor: 5.157

3.  A distinct phenotype of leg hyperreflexia in a Japanese family with Gerstmann-Sträussler-Scheinker syndrome (P102L).

Authors:  Takanori Takazawa; Ken Ikeda; Hirono Ito; Joe Aoyagi; Yoshikazu Nakamura; Ken Miura; Konosuke Iwamoto; Osamu Kano; Kiyokazu Kawabe; Yasuo Iwasaki
Journal:  Intern Med       Date:  2010-02-15       Impact factor: 1.271

4.  Proton magnetic resonance spectroscopy of a patient with Gerstmann-Straussler-Scheinker disease.

Authors:  K Konaka; M Kaido; Y Okuda; F Aoike; K Abe; T Kitamoto; T Yanagihara
Journal:  Neuroradiology       Date:  2000-09       Impact factor: 2.804

Review 5.  Prions mediated neurodegenerative disorders.

Authors:  W-J Huang; W-W Chen; X Zhang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2015-11       Impact factor: 3.507

Review 6.  Prionic diseases.

Authors:  Abelardo Q-C Araújo
Journal:  Arq Neuropsiquiatr       Date:  2013-09       Impact factor: 1.420

7.  Evidence of early cortical atrophy in MS: relevance to white matter changes and disability.

Authors:  N De Stefano; P M Matthews; M Filippi; F Agosta; M De Luca; M L Bartolozzi; L Guidi; A Ghezzi; E Montanari; A Cifelli; A Federico; S M Smith
Journal:  Neurology       Date:  2003-04-08       Impact factor: 9.910

8.  Organization of the Human Frontal Pole Revealed by Large-Scale DTI-Based Connectivity: Implications for Control of Behavior.

Authors:  Joseph M Orr; Harry R Smolker; Marie T Banich
Journal:  PLoS One       Date:  2015-05-06       Impact factor: 3.240

9.  Transmission Properties of Human PrP 102L Prions Challenge the Relevance of Mouse Models of GSS.

Authors:  Emmanuel A Asante; Andrew Grimshaw; Michelle Smidak; Tatiana Jakubcova; Andrew Tomlinson; Asif Jeelani; Shyma Hamdan; Caroline Powell; Susan Joiner; Jacqueline M Linehan; Sebastian Brandner; Jonathan D F Wadsworth; John Collinge
Journal:  PLoS Pathog       Date:  2015-07-02       Impact factor: 6.823

Review 10.  Epidemiological characteristics of human prion diseases.

Authors:  Cao Chen; Xiao-Ping Dong
Journal:  Infect Dis Poverty       Date:  2016-06-02       Impact factor: 4.520

View more
  1 in total

Review 1.  Role of Biomarkers for the Diagnosis of Prion Diseases: A Narrative Review.

Authors:  Miren Altuna; Iñigo Ruiz; María Victoria Zelaya; Maite Mendioroz
Journal:  Medicina (Kaunas)       Date:  2022-03-25       Impact factor: 2.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.